 Home > Medical News > Latest Medical News > Dolutegravir's first imitation: Qilu takes the lead in launching clinical trials

Dolutegravir's first imitation: Qilu takes the lead in launching clinical trials

 Last Update: 2022-01-12
 Source: Internet
 Author: User

Tags

sr cn 2

global investor

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 6, Qilu Pharmaceutical's "Dolutegravir Sodium Tablets" started the BE trial

From: Insight database (http://db.

Dolutegravir (DTG) is an anti-AIDS drug developed by GlaxoSmithKline/ViiV, which is an integrase inhibitor

According to the Insight database, there are currently 3 compound preparations approved for marketing of dolutegravir in addition to single drugs worldwide

Global sales of dolutegravir-related drugs

Dolutegravir sales trend over the years

From: Insight database (http://db.

At present, apart from Qilu, no other companies have applied for the start of clinical trials of dolutegravir generic drugs

Qilu Pharmaceuticals has recently not only increased its efforts in bio-innovative drugs, but has continued to be the king of traditional generic drugs, and is advancing extremely fast

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.